Tributyltin causes obesity and hepatic steatosis in male mice

Environmental Toxicology

Volumn 26, Issue 1, 2011, Pages 79-85

  Zuo, Zhenghong ^a   Chen, Shuzhen ^a   Wu, Tian ^a   Zhang, Jiliang ^a   Su, Ying ^a   Chen, Yixin ^a   Wang, Chonggang ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Hepatic steatosis; Hyperinsulinemia; Hyperleptinemia; Obesity; Tributyltin

Indexed keywords

HEPATIC STEATOSIS; HYPERINSULINEMIA; HYPERLEPTINEMIA; OBESITY; TRIBUTYLTIN;

ANTHROPOMETRY; CHEMICAL COMPOUNDS; HORMONES; MAMMALS; NUTRITION; ORGANOMETALLICS; TIN COMPOUNDS;

HEAT STABILIZERS;

ADIPONECTIN; TRIBUTYLTIN;

CATALYST; CHEMICAL POLLUTANT; DOSE-RESPONSE RELATIONSHIP; ENZYME ACTIVITY; GROWTH RATE; LIPID; METABOLISM; OBESITY; PESTICIDE APPLICATION; POLLUTION EXPOSURE; RODENT; TRIBUTYLTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FATTY LIVER; HYPERINSULINEMIA; HYPERLEPTINEMIA; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FATTY LIVER; GROWTH AND DEVELOPMENT; HORMONES; HYPERINSULINISM; LEPTIN; LIVER; MALE; MICE; OBESITY; TRIALKYLTIN COMPOUNDS; WEIGHT GAIN;

MUS;

EID: 79751483217     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20531     Document Type: Article

References (39)

1. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. 1996. Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252.
2. Auwerx J. 1999. PPARγ, the ultimate thrity gene. Diabetologia 42: 1033-1049.
3. Baillie-Hamilton PF. 2002. Chemical toxins: A hypothesis to explain the global obesity epidemic. J Altern Complem Med 8: 185-192.
4. Belfroid AC, Purperhart M, Ariese F. 2000. Organotin levels in seafood. Mar Pollut Bull 40: 226-232.
5. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549.
6. Chandran M, Phillips SA, Ciaraldi T, Henry RR. 2003. Adiponectin: More than just another fat cell hormone? Diabet Care 26: 2442-2450.
7. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. 2001. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108: 1875-1881.
8. Flier JS. 1998. Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 83: 1407-1413.
9. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
10. Golub M, Doherty J. 2004. Triphenyltin as a potential human endocrine disruptor. J Toxicol Environ Health B Crit Rev 7: 281-295.
11. Grote K, Stahlschmidt B, Talsness CE, Gericke C, Appel KE, Chahoud I. 2004. Effects of organotin compounds on pubertal male rats. Toxicology 202: 145-158.
12. Grun F, Blumberg B. 2006. Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147: S50-S55.
13. Grun F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, Gardiner DM, Kanno J, Iguchi T, Blumberg B. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20: 2141-2155.
14. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546.
15. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. 1997. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878-8883.
16. Heindel JJ. 2003. Endocrine disruptors and the obesity epidemic. Toxicol Sci 76: 247-249.
17. Inadera H, Shimomura, A. 2005. Environmental chemical tributyltin augments adipocyte differentiation. Toxicol Lett 159: 226-234.
18. IPCS. 1990. Tributyltin compounds. International Programme on Chemical Safety (Environmental Health Criteria 116). Geneva: World Health Organization.
19. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J-I. 2005. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway. Mol Pharmacol 67: 766-774.
20. Kannan K, Falandysz J. 1997. Butyltin residues in sediment, fish, fish-eating birds, harbour porpoise and human tissues from the Polish coast of the Baltic Sea. Mar Pollut Bull 34: 203-207.
21. Kannan K, Tanabe S, Iwata H, Tatsukawa R. 1995. Butyltins in muscle and liver of fish collected from certain Asian and Oceanian countries. Environ Pollut 90: 279-290.
22. Kannan K, Senthilkumar K, Giesy JP. 1999. Occurrence of butyltin compounds in human blood. Environ Sci Technol 33: 1776-1779.
23. Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556.
24. Kinlaw WB, Marsh B. 2004. Adiponectin and HIV-lipodystrophy: Taking HAART. Endocrinology 145: 484-486.
25. Lee CC, Wang T, Hsieh CY, Tien CJ. 2005. Organotin contamination in fishes with different living patterns and its implications for human health risk in Taiwan. Environ Pollut 137: 198-208.
26. Lee CC, Hsieh CY, Tien CJ. 2006. Factors influencing organotin distribution in different marine environmental compartments, and their potential health risk. Chemosphere 65: 547-559.
27. Makita Y, Omura M, Tanaka A, Kiyohara C. 2005. Effects of concurrent exposure to tributyltin and 1, 1-dichloro-2, 2 bis (p-chlorophenyl) ethylene (p, p'-DDE) on immature male Wistar rats. Basic Clin Pharmacol Toxicol 97: 364-368.
28. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H, Honda, K. 2002. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 43: 676-684.
29. Masuno H, Okamoto S, Iwanami J, Honda K, Shiosaka T, Kidani T, Sakayama K, Yamamoto, H. 2003. Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells. Toxicol Sci 75: 314-320.
30. Meier U, Gressner AM. 2004. Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50: 1511-1525.
31. Mlinar B, Marc J, Janez A, Pfeifer, M. 2007. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375: 20-35.
32. Newbold RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN. 2007. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 23: 290-296.
33. Nielsen JB, Strand J. 2002. Butyltin compounds in human liver. Environ Res 88: 129-133.
34. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
35. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307-312.
36. Stridh H, Fava E, Single B, Nicotera P, Orrenius S, Leist M. 1999. Tributyltin-induced apoptosis requires glycolytic adenosine trisphosphate production. Chem Res Toxicol 12: 874-882.
37. Takahashi S, Mukai H, Tanabe S, Sakayama K, Miyazaki T, Masuno H. 1999. Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products. Environ Pollut 106: 213-218.
38. Wauters M, Considine RV, Van Gaal LF. 2000. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143: 293-311.
39. Zhu X, Xing M, Lou J, Wang X, Fu W, Xu L.2007.Apoptotic related biochemical changes in human amnion cells induced by tributyltin.Toxicology 230:45-52.